P3.02b-003 Second-Line Afatinib versus Erlotinib for Patients with Squamous Cell Carcinoma of the Lung (LUX-Lung 8): Analysis of Tumor and Serum Biomarkers
Makaleler > Tam Makale · 2017
Yazarlar: Enriqueta Felip, Jean-Charles Soria, Manuel Cobo, Shun Lu, Kostas Syrigos, Ki Hyeong Lee, Erdem GÖKER, Vassilis Georgoulias, Wei Li, Salih Guclu, Dolores Isla, Young Joo Min, Alessandro Morabito, Andrea Ardizzoni, Shirish Gadgeel, Nicholas Dupuis, Neil Gibson, Nicole Krämer, Claudia Bühnemann, Flavio Solca, Eva Ehrnrooth, Glenwood Goss
Journal of Thoracic Oncology, Uluslararası, Wos, 2017, cilt 12, ss S1186-S1187